Taking Charge of Your Health

(Again, a long but enlightening article from A MIDWESTERN DOCTOR.  Just a small fragment is included here.)

Why Medicine Won’t Cure You (and What’s Finally Changing)

The predatory business model that requires lifelong patients faces its first federal challenge with Kennedy’s historic SSRI initiative

Story at a Glance:

  • No industry, organization, or cause tasked with solving a problem will actually solve it, because the problem disappearing threatens their economic livelihood or political power—a dynamic visible everywhere from non-profits which constantly seek donations but never produce results to dating apps that deliberately prevent users from finding partners and leaving the platform.
  • The pharmaceutical industry has perfected this model: drugs are designed to be taken perpetually rather than cure, side effects create demand for additional drugs, and the entire regulatory apparatus is structured to protect this status quo by suppressing affordable natural therapies like DMSO that challenge it.
  • SSRIs epitomize this dynamic—massively overprescribed, frequently life-ruining, and nearly impossible to withdraw from—yet for decades, the industry successfully kept all criticism of them out of mainstream discourse.
  • Recently, efforts to connect SSRIs to mass shootings shifted the Overton window, making SSRI injuries gradually become acceptable to discuss, culminating in Secretary Kennedy recently holding a panel where victims shared devastating testimonies of what SSRIs had done to their lives.
  • Kennedy then announced a multiagency federal effort to combat inappropriate SSRI prescribing, train providers in how to correctly taper patients off antidepressants, and provide non-pharmaceutical alternatives—marking the first time in memory a federal health initiative has aimed to help get patients off a major drug class rather than on one.
  • Conversely, those who embrace the constant challenge of actually solving problems rather than managing them—in medicine and elsewhere—consistently find it is the most fulfilling way to practice, which is why Kennedy’s approach of giving physicians a supportive framework to break from the status quo holds so much promise.

When I was in high school, I observed a few discouraging events which led me to postulate: “no industry, organization or cause tasked with solving a problem will actually solve it because the problem disappearing threatens their economic livelihood or political power.” Since that time, I have observed more examples than I can count in so many different spheres that I’ve accepted this dynamic is a common feature of society, and likewise, have come across many similar observations by others, my favorite of which was:

Nothing is so permanent as a temporary government program—Milton Friedman

Recently two noteworthy examples of this principle came to my attention.

First, a frustrated patient shared with me they’d recently learned all of the online dating apps had switched from formats which allowed people to find suitable long term partners (e.g., with lengthy compatibility surveys) to ones which prevented people from matching because if someone found a good match on a platform, they would then stop paying more money for the service, whereas if they were hooked on it and spending hours each day trying to find someone, they would be a sustainable source of revenue. More remarkably, once one company figured out this approach made more money, they bought out all of their competitors (sometimes with threats of spurious lawsuits) and shifted them all over to this predatory model as well (all of which is detailed in these six articles1,2,3,4,5,6). I found this example noteworthy as:

  • One of the greatest sources of distress I find in patients (particularly now) are relationship challenges, particularly a lack of one, and I believe much of this traces back to apps taking over courtship.
  • Beyond the personal cost this dynamic creates, one of the largest challenges most developed countries are facing is a low birthrate which is primarily due to low marriage rates. My belief, in turn, is that many of the heavily contested policies we are seeing (e.g., reducing social support for the elderly, mass migration, or replacing workers with robots or AI) ultimately are due to the fact policy makers believe the declining birthrate means it will not be viable for the younger generation to support the society (particularly the elderly) so alternatives need to be found regardless of how objectionable they are.
  • A common cycle predatory industries in America follow is presenting a “superior” way to meet an essential need of humanity that replaces the traditional one that’s worked, then once the old one is completely displaced, tightening the screws with the new one (to milk as much out of the population as possible) until things are far worse than what preceded it and massive social cost is accrued (e.g., the Rockefellers did this in various ways with food, energy, and medicine).

Note: because online dating has now become so bad, the companies that monopolized the market are starting to lose a lot of users and money, signaling there may be a chance for this cycle to reset itself.

Second, a federal DOJ indictment recently charged the SPLC (one of the country’s leading civil rights groups that built its reputation fighting hate) with wire fraud, bank fraud, and money laundering. Prosecutors alleged it paid over $3 million in donor funds to informants embedded in white supremacist groups (including the KKK and National Alliance) while soliciting donations to “end hate,” and that one paid informant participated in planning chats, attended, and helped with logistics for the 2017 Charlottesville Unite the Right rally. Many, in turn, were outraged about this, in part because of how much political capital was extracted from the event (e.g., Biden made opposing it a central justification for his 2020 presidential campaign and Harris to a lesser extent did so as well in 2024) but also because of just how much money it made:

Unfortunately, these are far from isolated examples, and it would be impossible for me to cover even a sliver of them here. As such, this article will focus on how this principle applies to medicine and why I believe beyond greed, complacency also plays a central role in the continual recurrence of this dynamic across societies.

The Forgotten Side of Medicine is a reader-supported publication. To receive new posts and support my work, consider becoming a free or paid subscriber. To see how others have benefitted from this newsletter, click here!

Is Money The Root Of All Evil?

The origins of our faith and devotion to money have raised many questions throughout the ages. The love of money, in turn, has long been recognized as one of the most powerful forces for twisting human hearts towards evil (which often results in immense destruction to the people or the environment), while simultaneously, its value is often completely arbitrary—money gets printed and then assumes value because everyone holds a collective faith in it the ruling class controls us through. At the same time, money is a remarkable force for both developing and organizing society, and many of the things we depend upon are only available to us because of the economic system we live within.

When the question of money is looked at, it is often seen through a lens of greed being a deadly sin. However, I would argue the core issue is that for many people, effectively accumulating money becomes the foundational axiom (guiding principle) used to navigate life, causing them to rationalize a variety of unethical positions (they often lie about) to make money, because their internal algorithm will frequently default to the choice that acquires more money. Recognizing this, in turn, provides an invaluable tool for understanding the world around you, as the motivations of others often become far clearer once you cut through all their rhetoric and view things strictly through what they stand to profit from.

Algorithms of Business

In the same way that a default behavior to seek the most profitable choice helps to explain many of the individual actions we observe around us, businesses also follow a relatively predictable set of behaviors aimed at optimizing profit, which you can see in a wide range of industries.

In general, most large businesses aim for the following, prioritizing whichever are most feasible:

  • Continual growth
  • High markups on their product
  • The widest possible market
  • Market exclusivity (to protect and maximize sales)
  • Repeating sales far into the future

The main problem with this framework, which society largely applauds and equates with success, is that businesses routinely prioritize profit, even when it conflicts with the interests of customers or society. Because of this, we frequently see:

  • Artificial “needs” being created through marketing, making unnecessary products seem essential.
  • Harmful products (environmentally damaging or toxic to humans) being aggressively marketed and kept on the market despite the damage.
  • Extreme markups on essential products, pushing dependent customers closer to poverty.
  • Monopolies and exclusivity tactics used to block competing (and often better) solutions from entering the market.
  • Products deliberately designed for repeat purchases rather than full solutions, such as planned obsolescence or proprietary consumables (e.g., Gillette’s classic “razor-and-blades” sales model, and its modern equivalents like Amazon’s sinus irrigator that only works with its expensive proprietary pods that you quickly run out of).

The pharmaceutical industry, not surprisingly, excels in all of these, which helps to explain why they have managed to sustain steady growth for decades, and why one-fifth of all money spent in the United States goes to healthcare despite our country receiving very poor returns on that investment.

Note: annual adult vaccines (which frequently do nothing. particularly because they are often for the wrong strain) are an excellent example of an unsafe, unproven and ineffective product that is pushed on everyone because it fulfills the need for perpetually recurring sales.

to read the rest of the article (Concernning such things as “Lifelong Patients”, DMSO, Antidepressants, etc.) go to:  https://www.midwesterndoctor.com/p/why-medicine-wont-cure-you-and-whats?publication_id=748806&post_id=197079403&isFreemail=true&r=19iztd&triedRedirect=true&utm_source=substack&utm_medium=email

The Pharmaceutical Mafia Exposed

The pharmaceutical industry is dangerous to health. Further proof with COVID-19

Abstract

Background: The COVID-19 period highlights a huge problem that has been developing for decades, the control of science by industry. In the 1950s, the tobacco industry set the example, which the pharmaceutical industry followed. Since then, the latter has been regularly condemned for illegal marketing, misrepresentation of experimental results, dissimulation of information about the dangers of drugs, and considered as criminal. Therefore, this study was conducted to show that knowledge is powerfully manipulated by harmful corporations, whose goals are: 1/financial; 2/to suppress our ability to make choices to acquire global control of public health.

Methods: Pharmaceutical industry techniques for manipulating science and COVID-19 reporting were reviewed. Several sources of official documents were used: PubMed; National Institutes of Health resources; pharmaceutical companies; policy documents; national newspapers and news agencies; and books by prominent professionals (scientific and legal). A few studies have not been published in peer-reviewed journals; however, they have been conducted by reputable scientists in their respective fields.

Results: Since the beginning of COVID-19, we can list the following methods of information manipulation which have been used: falsified clinical trials and inaccessible data; fake or conflict-of-interest studies; concealment of vaccines’ short-term side effects and total lack of knowledge of the long-term effects of COVID-19 vaccination; doubtful composition of vaccines; inadequate testing methods; governments and international organizations under conflicts of interest; bribed physicians; the denigration of renowned scientists; the banning of all alternative effective treatments; unscientific and liberticidal social methods; government use of behavior modification and social engineering techniques to impose confinements, masks, and vaccine acceptance; scientific censorship by the media.

Conclusion: By supporting and selecting only the one side of science information while suppressing alternative viewpoints, and with obvious conflicts of interest revealed by this study, governments and the media constantly disinform the public. Consequently, the unscientifically validated vaccination laws, originating from industry-controlled medical science, led to the adoption of social measures for the supposed protection of the public but which became serious threats to the health and freedoms of the population.

Keywords: Behavior modification; COVID-19; Conflicts of interest; Scientific censorship; Side effects; Vaccination.

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1:

Similar articles

from:    https://pubmed.ncbi.nlm.nih.gov/36324959/

Cancer Studies Funded by

Industry-backed studies more prominent at meetings

By Genevra Pittman

NEW YORK | Tue Jun 18, 2013 3:11pm EDT

(Reuters Health) – Studies that are funded by pharmaceutical companies or involve industry-backed scientists tend to be more prominent at cancer meetings than independent studies, a new report suggests.

“Figuring out the reasons behind these findings is critical,” said Dr. Beverly Moy, who led the analysis at Massachusetts General Hospital Cancer Center in Boston.

She and her colleagues also found the proportion of presentations with a financial conflict of interest increased between the 2006 and 2011 American Society of Clinical Oncology (ASCO) annual meetings.

“As long as the studies are done well, I don’t think there’s any objection to them becoming more prominent,” Moy told Reuters Health.

However, she added, past evidence suggests industry-funded research is more likely to be published if it’s positive – in favor of a product or pill – than if it’s negative, a phenomenon known as publication bias.

So it’s important to make sure relationships between scientists and companies stay “productive,” she said, rather than become untrustworthy.

The researchers analyzed conflicts of interest, ratings and conference prominence for more than 20,700 scientific abstracts, or research summaries, presented at ASCO meetings in 2006, 2008, 2009, 2010 and 2011.

Over those years, the proportion of studies reporting a financial conflict of interest rose from 33 percent to 38 percent. Their abstracts were rated as slightly better quality by peer reviewers, on average: 2.76 on a scale from 1 to 5, where lower is better, versus 3.01 for studies without a link to industry.

Abstracts tied to pharmaceutical companies were also more likely to have their own session at a conference, or to be presented during a talk or poster discussion. For example, the ratio of industry-supported to non-supported studies was twice as high among oral presentations as among general posters, which receive less attention.

The findings appear in the Journal of Clinical Oncology, which is published by ASCO.

“With the increase in these relationships, we really need to figure out how to manage them,” Moy said. It’s possible, she said, that such academic-industry teams “yield an alliance that produces better research.”

Alternatively, companies might seek out the most prominent researchers for partnerships, or vice-versa.

“I think a lot of the work that gets a high profile is, of necessity, work that has a relationship with industry. They are, after all, providers of most of the ‘breakthrough’ drugs,” said Dr. David Johnson, chair of internal medicine at the UT Southwestern School of Medicine in Dallas.

But the study does serve as a caution as well, said Johnson, who has studied conflicts of interest in medical research but wasn’t involved in this analysis.

“It again points out that there is this potential for greater and greater influence in the relationship of industry and the direction that biomedical research takes, and we have to constantly be on guard,” he told Reuters Health.

“I think there is a pretty clear influence that industry has on research that’s not always bad, but it’s not always good either … We just have to be really, really cautious.”

SOURCE: bit.ly/128Yg4U Journal of Clinical Oncology, online June 17, 2013.

from:    http://www.reuters.com/article/2013/06/18/us-health-industry-study-idUSBRE95H16R20130618